hers.com semaglutide Hims? Hers? It's Novo Nordisk's Market Now Week 2 Results – Down

Adding to library failed Follow podcast failed Unfollow podcast failed Narrated by: Send a text SUPPORT OUR WORK: OTPLinks.com Story 1 Fractyl Healths One-and-Done Gene Therapy for Obesity Fractyl Health just dropped preclinical results showing their GLP-1 + GIP gene therapy candidate RJVA-002 produced almost 30% weight loss in mice after a single dose

Dose may be too low

Dashboard metrics can include fewer ER visits and decreased use of other medications as members lose weight

"I feel like, like a whole new life was started for me," Steensma said

And so its Arizona

This was reported in 8.8% of participants on the 9 mg dose and 20.9% on the 12 mg dose, compared to just 0.7% on placebo